healthcare

healthcare Articles

Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm...
Artificial intelligence and robots are poised to play a bigger role in medicine and health care. Will robots replace doctors? When will that begin to happen? Do we know what to expect?
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
Ascendis Pharma shares spiked early Monday as the result of positive top-line results from its late-stage growth hormone study in children.
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has some ideas for what the big movers could be.
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista...
ImmunoGen shares were halved on Friday after the firm reported late-stage results from its ovarian cancer study.
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
The February 15 short interest data have been compared with the previous figures, and short interest moves in these selected marijuana stocks were mixed.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Tandem Diabetes shares soared after it reported better-than-expected quarterly results and announced management changes.
Zynerba Pharmaceuticals shares jumped on Tuesday after the company announced that it has received a key patent from the U.S. Patent and Trademark Office.
The FDA has warned a California company against marketing its thermography device as a stand-alone test for breast cancer and other conditions. The device has only been approved for use only when...